Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Antibodies
Immunotherapy
Antibody-drug-conjugate
Indications:
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Skin and subcutaneous tissue / dermatology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 44
On the market: 8
Description:
Genmab A/S is a biotechnology company that specializes in the development of antibody therapeutics for the treatment of cancer. The company's product Acasunlimab (DuoBody®-PD-L1×4-1BB) is an investigational, bispecific antibody immunotherapy designed to elicit an antitumor response via conditional activation of 4-1BB on T cells and natural killer (NK) cells, which is strictly dependent on simultaneous binding to PD-L1. The company's another product Acasunlimab (DuoBody®-PD-L1×4-1BB) is...
